# Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor

> **NCT00079079** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 34 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00079079
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10-27
- **Primary completion:** 2008-09-29
- **Final completion:** 2009-02-10
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00079079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00079079, "Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00079079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*